Healthy Habits Ripe for the Picking Awareness of the link between cancer risk and a diet lacking fruits and vegetables has been declining. by Carisa D. Brewster Cervical Cancer Screening Guideline Updated A new version of the American Cancer Society’s cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method. by Anna Azvolinsky Anal Cancer Diagnoses and Deaths Are Rising in the U.S. Study underscores importance of early detection and prevention. by Jane Langille Forward Look Cancer Death Rate Decline Makes Headlines Experts say it’s necessary to look behind the statistics. by Delia O’Hara Healthy Habits One Drink, Too Many? Drinking at any level increases cancer risk. by Ashley P. Taylor FORWARD LOOK Makers of E-Cigarettes Tout Role in Smoking Cessation Studies provide little evidence to support this claim. by Stephen Ornes Healthy Habits Go With Your Gut Can eating yogurt reduce your risk of developing lung cancer? by Karen Olsen FORWARD LOOK What’s Next A new way to detect Barrett’s esophagus. by Bradley Jones Medicare Coverage for Next-Generation Sequencing Tests Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests. by Ashley P. Taylor Drinking After a Diagnosis A study illuminates the alcohol consumption habits of cancer survivors. by Jen Tota McGivney next Cancer Talk Why Do African Americans Have Increased Breast Cancer Mortality? Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates. by Marci A. Landsmann Liquid Biopsies May Ease Enrollment in Clinical Trials A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials. by Emma Yasinski What Is Tumor Mutational Burden? The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types. by Anna Azvolinsky Drafting a Medical Team Going through cancer treatment and ensuing complications is never easy, but surrounding yourself with the right key players can help, writes pancreatic cancer survivor Rob Weker. by Rob Weker More Posts